NO20004663L - Anti-tumor-midler - Google Patents

Anti-tumor-midler

Info

Publication number: NO20004663L
Authority: NO; Norway
Prior art keywords: alkyl; hydrogen; tumor agents; benzensulphonyloxy; alkynylimino
Prior art date: 1998-03-20

Application number

NO20004663A

Other languages

English (en)

Other versions

NO20004663D0 (no

Inventor

Francis Thomas Boyle

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-20

Filing date

2000-09-19

Publication date

2000-11-13

2000-09-19 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2000-09-19 Publication of NO20004663D0 publication Critical patent/NO20004663D0/no

2000-11-13 Publication of NO20004663L publication Critical patent/NO20004663L/no

Links

239000002246 antineoplastic agent Substances 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000005277 alkyl imino group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
230000001028 anti-proliverative effect Effects 0.000 abstract 1
-1 benzensulphonyloxy Chemical group 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Saccharide Compounds (AREA)
Hydrogenated Pyridines (AREA)

NO20004663A 1998-03-20 2000-09-19 Anti-tumor-midler NO20004663L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9805868.8A GB9805868D0 (en)	1998-03-20	1998-03-20	Anti-tumour agents
PCT/GB1999/000786 WO1999048860A1 (en)	1998-03-20	1999-03-16	Anti-tumour agents

Publications (2)

Publication Number	Publication Date
NO20004663D0 NO20004663D0 (no)	2000-09-19
NO20004663L true NO20004663L (no)	2000-11-13

Family

ID=10828860

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20004663A NO20004663L (no)	1998-03-20	2000-09-19	Anti-tumor-midler

Country Status (19)

Country	Link
US (1)	US6472435B1 (no)
EP (1)	EP1064257B1 (no)
JP (1)	JP2002507592A (no)
KR (1)	KR20010042056A (no)
CN (1)	CN1178900C (no)
AT (1)	ATE231836T1 (no)
AU (1)	AU746715B2 (no)
BR (1)	BR9908934A (no)
CA (1)	CA2319335A1 (no)
DE (1)	DE69905143T2 (no)
DK (1)	DK1064257T3 (no)
ES (1)	ES2192036T3 (no)
GB (1)	GB9805868D0 (no)
IL (1)	IL138590A (no)
NO (1)	NO20004663L (no)
NZ (1)	NZ506011A (no)
PT (1)	PT1064257E (no)
WO (1)	WO1999048860A1 (no)
ZA (1)	ZA200004386B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9805866D0 (en)	1998-03-20	1998-05-13	Zeneca Ltd	Anti-tumour agents
US6413533B1 (en) *	1998-05-07	2002-07-02	The University Of Tennessee Research Corporation	Method for chemoprevention of prostate cancer
US20060099712A1 (en) *	2004-11-08	2006-05-11	Eastman Kodak Company	Correlation of anti-cancer activity of dyes with redox potentials
BRPI0608419A8 (pt) *	2005-03-11	2018-04-03	Medical Instill Tech Inc	Aparelho e método para moldagem e enchimento de um recipiente
US20110039943A1 (en) *	2005-03-14	2011-02-17	Robert Alonso	Methods for treating skin disorders with topical nitrogen mustard compositions
US7872050B2 (en) *	2005-03-14	2011-01-18	Yaupon Therapeutics Inc.	Stabilized compositions of volatile alkylating agents and methods of using thereof
US8501818B2 (en) *	2005-03-14	2013-08-06	Ceptaris Therapeutics, Inc.	Stabilized compositions of alkylating agents and methods of using same
US20110104250A1 (en) *	2007-09-07	2011-05-05	Mccarley Robin L	Redox-gated Liposomes
SI2273876T1 (sl)	2008-03-27	2019-09-30	Helsinn Healthcare Sa	Stabilizirani sestavki alkilirajočih sredstev in metod za uporabo le-teh
KR101006166B1 (ko) *	2008-12-10	2011-01-07	건국대학교 산학협력단	지하철 역 선로에 설치되는 자기성 분진 수거 장치 및 그 방법
BR112013030370A2 (pt)	2011-05-26	2017-08-08	Apex Therapeutics Inc	compostos de quinona para tratamento de doenças mediadas por ape1
WO2012167122A1 (en)	2011-06-03	2012-12-06	Indiana University Research And Technology Corporation	Compounds, compositions and methods for treating oxidative dna damage disorders
US10730903B2 (en)	2016-09-19	2020-08-04	Memorial Sloan-Kettering Cancer Center	Adenosine analogs as methyltransferase inhibitors for treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2862107D1 (en)	1977-12-02	1982-11-18	Takeda Chemical Industries Ltd	Glucosamine-peptide derivatives and their pharmaceutical compositions
JPS58177934A (ja)	1982-04-13	1983-10-18	Takeda Chem Ind Ltd	ベンゾキノン誘導体
NZ240785A (en) *	1991-11-28	1995-08-28	Cancer Res Campaign Tech	Substituted nitro aniline derivatives and medicaments
GB9805866D0 (en)	1998-03-20	1998-05-13	Zeneca Ltd	Anti-tumour agents

1998
- 1998-03-20 GB GBGB9805868.8A patent/GB9805868D0/en not_active Ceased
1999
- 1999-03-16 WO PCT/GB1999/000786 patent/WO1999048860A1/en not_active Ceased
- 1999-03-16 AU AU28467/99A patent/AU746715B2/en not_active Ceased
- 1999-03-16 AT AT99909098T patent/ATE231836T1/de not_active IP Right Cessation
- 1999-03-16 DK DK99909098T patent/DK1064257T3/da active
- 1999-03-16 US US09/646,464 patent/US6472435B1/en not_active Expired - Fee Related
- 1999-03-16 EP EP99909098A patent/EP1064257B1/en not_active Expired - Lifetime
- 1999-03-16 CN CNB998040908A patent/CN1178900C/zh not_active Expired - Fee Related
- 1999-03-16 ES ES99909098T patent/ES2192036T3/es not_active Expired - Lifetime
- 1999-03-16 KR KR1020007010400A patent/KR20010042056A/ko not_active Ceased
- 1999-03-16 BR BR9908934-3A patent/BR9908934A/pt not_active IP Right Cessation
- 1999-03-16 JP JP2000537845A patent/JP2002507592A/ja active Pending
- 1999-03-16 NZ NZ506011A patent/NZ506011A/xx unknown
- 1999-03-16 PT PT99909098T patent/PT1064257E/pt unknown
- 1999-03-16 DE DE69905143T patent/DE69905143T2/de not_active Expired - Fee Related
- 1999-03-16 IL IL13859099A patent/IL138590A/en not_active IP Right Cessation
- 1999-03-16 CA CA002319335A patent/CA2319335A1/en not_active Abandoned
2000
- 2000-08-24 ZA ZA200004386A patent/ZA200004386B/en unknown
- 2000-09-19 NO NO20004663A patent/NO20004663L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1064257A1 (en)	2001-01-03
EP1064257B1 (en)	2003-01-29
DE69905143D1 (de)	2003-03-06
NZ506011A (en)	2002-10-25
DE69905143T2 (de)	2003-11-20
BR9908934A (pt)	2005-10-25
PT1064257E (pt)	2003-06-30
AU2846799A (en)	1999-10-18
ZA200004386B (en)	2002-01-30
ATE231836T1 (de)	2003-02-15
CN1293656A (zh)	2001-05-02
JP2002507592A (ja)	2002-03-12
CN1178900C (zh)	2004-12-08
CA2319335A1 (en)	1999-09-30
AU746715B2 (en)	2002-05-02
GB9805868D0 (en)	1998-05-13
ES2192036T3 (es)	2003-09-16
NO20004663D0 (no)	2000-09-19
DK1064257T3 (da)	2003-05-26
IL138590A0 (en)	2001-10-31
IL138590A (en)	2004-08-31
US6472435B1 (en)	2002-10-29
KR20010042056A (ko)	2001-05-25
WO1999048860A1 (en)	1999-09-30

Legal Events

Date	Code	Title	Description
2006-10-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ATE231836T1 (de)	2003-02-15	Anti-tumor-mittel
EP1023308A4 (en)	2002-05-29	INHIBITORS OF NUCLEOSIDE METABOLISM
PL368409A1 (en)	2005-03-21	Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a? receptor and their use as medicaments
MXPA05009359A (es)	2005-11-04	Tetrahidroisoquinolinas 2,5- y 2,6 substituidas para uso como moduladores 5-ht6.
TR200100075T2 (tr)	2001-08-21	2-Kuinolon ihtiva eden farmasötik bileşimler
NZ334954A (en)	2000-08-25	Substituted heterocycles as anti-tumor agents
MY139612A (en)	2009-10-30	Benzoxazine derivatives as 5-th6 modulators and uses thereof
MY118004A (en)	2004-08-30	Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
ATE248167T1 (de)	2003-09-15	Tetrazole derivate
TR200101979T2 (tr)	2001-12-21	Antidepresyon tedavisi için 5HT1 antagonistleri.
IL114968A (en)	1999-08-17	1,4-dihydropyridine compounds and pharmaceutical compositions containing them
ES467069A1 (es)	1979-10-16	Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
ZA995321B (en)	2000-02-22	Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them.
BR9604907A (pt)	1998-07-21	Derivados de nucleosideos hamocarbociclico de pirimidinodiona substituida aniviral e métodos de preparo dos mesmos e composiçoes contendo tais derivados como principios ativos
ATE231835T1 (de)	2003-02-15	Anti-tumor-mittel
PT944618E (pt)	2004-02-27	Novos compostos de n-benzenossulfonilo-1-prolina processo de preparacao e utilizacao em terapia
KR970706280A (ko)	1997-11-03	5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)
KR960007560A (ko)	1996-03-22	신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
TW200509927A (en)	2005-03-16	Chronic obstructive pulmonary disease therapeutic agent and method of treating chronic obstructive pulmonary disease using the same